During the past decade, Istituto Oncologico di Bari, U.O. di Oncologia Medica e Sperimentale conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Istituto Oncologico di Bari, U.O. di Oncologia Medica e Sperimentale" #1 collaborator was "Clinical Trials Promoting Group (APRIC/CTPG)" with 1 trials as a collaborator, "Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente" with 1 trials as a collaborator, "Gruppo Oncologico Italia Meridionale" with 1 trials as a collaborator, "Gruppo Oncologico Italiano di Ricerca Clinica(GOIRC)" with 1 trials as a collaborator and "Gruppo Oncologico del Lazio (GOL)" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Istituto Oncologico di Bari, U.O. di Oncologia Medica e Sperimentale" are "Advanced Non-Small Cell Lung Cancer" (1 trials), "Advanced Non-small Cell Lung Cancer" (1 trials), "Non-Small Cell Lung Cancer" (1 trials) and "Ovarian Cancer" (1 trials). Many other conditions were trialed in "Istituto Oncologico di Bari, U.O. di Oncologia Medica e Sperimentale" in a lesser frequency.

Most popular intervention types in "Istituto Oncologico di Bari, U.O. di Oncologia Medica e Sperimentale" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "cisplatin" (3 trials), "gemcitabine" (3 trials), "carboplatin" (1 trials), "erlotinib" (1 trials) and "liposomal doxorubicin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Istituto Oncologico di Bari, U.O. di Oncologia Medica e Sperimentale" are 3 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Istituto Oncologico di Bari, U.O. di Oncologia Medica e Sperimentale". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Istituto Oncologico di Bari, U.O. di Oncologia Medica e Sperimentale, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Istituto Oncologico di Bari, U.O. di Oncologia Medica e Sperimentale, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".